These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7642746)

  • 1. Enhancement of phagocytosis by dynorphin A in mouse peritoneal macrophages.
    Ichinose M; Asai M; Sawada M
    J Neuroimmunol; 1995 Jul; 60(1-2):37-43. PubMed ID: 7642746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Endorphin enhances phagocytosis of latex particles in mouse peritoneal macrophages.
    Ichinose M; Asai M; Sawada M
    Scand J Immunol; 1995 Sep; 42(3):311-6. PubMed ID: 7660064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of phagocytosis in mouse peritoneal macrophages by fragments of acidic fibroblast growth factor (aFGF).
    Ichinose M; Sawada M; Sasaki K; Oomura Y
    Int J Immunopharmacol; 1998; 20(4-5):193-204. PubMed ID: 9730255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of phagocytosis by corticostatin I (CSI) in cultured mouse peritoneal macrophages.
    Ichinose M; Asai M; Imai K; Sawada M
    Immunopharmacology; 1996 Nov; 35(2):103-9. PubMed ID: 8956973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A flow cytometric assay reveals an enhancement of phagocytosis by platelet activating factor in murine peritoneal macrophages.
    Ichinose M; Hara N; Sawada M; Maeno T
    Cell Immunol; 1994 Jul; 156(2):508-18. PubMed ID: 8025959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of vasoactive intestinal peptide (VIP) on phagocytosis in mouse peritoneal macrophages.
    Ichinose M; Sawada M; Maeno T
    Regul Pept; 1994 Dec; 54(2-3):457-66. PubMed ID: 7536335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects and mechanism of action of synthetic peptide octarphin].
    Nekrasova IuN; Sadovnikov VB; Zolotarev IuA; Navolotskaia EV
    Bioorg Khim; 2010; 36(5):638-45. PubMed ID: 21063450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynorphin and neoendorphin peptides decrease dorsal root ganglion neuron calcium-dependent action potential duration.
    Werz MA; Macdonald RL
    J Pharmacol Exp Ther; 1985 Jul; 234(1):49-56. PubMed ID: 2409273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynorphin block of N-methyl-D-aspartate channels increases with the peptide length.
    Chen L; Huang LY
    J Pharmacol Exp Ther; 1998 Mar; 284(3):826-31. PubMed ID: 9495839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-stimulating peptides VKGFY and cyclo(VKGFY) act through nonopioid beta-endorphin receptors.
    Navolotskaya EV; Zargarova TA; Malkova NV; Zharmukhamedova TY; Kolobov AA; Kampe-Nemm EA; Yurovsky VV; Lipkin VM
    Biochem Biophys Res Commun; 2003 Apr; 303(4):1065-72. PubMed ID: 12684044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by opioids of phagocytosis in peritoneal macrophages.
    Casellas AM; Guardiola H; Renaud FL
    Neuropeptides; 1991 Jan; 18(1):35-40. PubMed ID: 1675453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of phagocytosis by calcitonin gene-related peptide (CGRP) in cultured mouse peritoneal macrophages.
    Ichinose M; Sawada M
    Peptides; 1996; 17(8):1405-14. PubMed ID: 8971938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-constrained endomorphin analogs display differential antinociceptive mechanisms in mice after spinal administration.
    Wang Y; Zhou J; Liu X; Zhao L; Wang Z; Zhang X; Wang K; Wang L; Wang R
    Peptides; 2017 May; 91():40-48. PubMed ID: 28363796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid receptor selectivity of dynorphin gene products.
    James IF; Fischli W; Goldstein A
    J Pharmacol Exp Ther; 1984 Jan; 228(1):88-93. PubMed ID: 6141278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of microiontophoretically-applied opioid peptides on Purkinje cells in the cat cerebellum.
    Taguchi K; Abe K; Chyuma T; Kato M; Shigenaga T; Kushida K; Chikuma T
    Acta Pharmacol Sin; 2000 Oct; 21(10):877-84. PubMed ID: 11501037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A flow cytometric assay reveals a suppression of phagocytosis by rabbit defensin NP-3A in mouse peritoneal macrophages.
    Ichinose M; Sawada M
    Microbiol Immunol; 1995; 39(5):365-7. PubMed ID: 7565178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynorphin peptides: antagonists of melanocortin receptors.
    Quillan JM; Sadée W
    Pharm Res; 1997 Jun; 14(6):713-9. PubMed ID: 9210186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible regulatory role of dynorphin-(1-13) on narcotic-induced changes in naloxone efficacy.
    Tulunay FC; Jen MF; Chang JK; Loh HH; Lee NM
    Eur J Pharmacol; 1981 Dec; 76(2-3):235-9. PubMed ID: 6277644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynorphin and related opioid peptides enhance tumoricidal activity mediated by murine peritoneal macrophages.
    Foster JS; Moore RN
    J Leukoc Biol; 1987 Aug; 42(2):171-4. PubMed ID: 2439627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The opioid peptide dynorphin A induces leukocyte responses via integrin Mac-1 (αMβ2, CD11b/CD18).
    Podolnikova NP; Brothwell JA; Ugarova TP
    Mol Pain; 2015 Jun; 11():33. PubMed ID: 26036990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.